Indiana Code 25-26-24-22. Rules; standards; intervention and treatment
(1) Information collection and retrieval procedures for the INSPECT program, including the controlled substances to be included in the program required under section 17 of this chapter.
Terms Used In Indiana Code 25-26-24-22
- board: refers to the Indiana board of pharmacy. See Indiana Code 25-26-24-1
- controlled substance: has the meaning set forth in IC 35-48-1-9. See Indiana Code 25-26-24-2.5
- dispense: means to deliver a controlled substance to an ultimate user or research subject by or pursuant to the lawful order of a practitioner and includes the prescribing, administering, packaging, labeling, or compounding necessary to prepare the substance for that delivery. See Indiana Code 25-26-24-3
- ephedrine: includes only ephedrine that is dispensed pursuant to a prescription or drug order. See Indiana Code 25-26-24-4
- INSPECT: means the Indiana scheduled prescription electronic collection and tracking program established by IC 25-1-13-4. See Indiana Code 25-26-24-7
- patient: means an individual who has requested or received health care services from a provider for the examination, treatment, diagnosis, or prevention of a physical or mental condition. See Indiana Code 25-26-24-10
- practitioner: means a physician, dentist, veterinarian, podiatrist, nurse practitioner, scientific investigator, pharmacist, hospital, or other institution or individual licensed, registered, or otherwise permitted to distribute, dispense, conduct research with respect to, or administer a controlled substance in the course of professional practice or research in the United States. See Indiana Code 25-26-24-11
- prescription: means an order for medication that is dispensed to or for a recipient. See Indiana Code 25-26-24-12
- pseudoephedrine: includes only pseudoephedrine that is dispensed pursuant to a prescription or drug order. See Indiana Code 25-26-24-13
(3) Requirements for the development and installation of online electronic access by the board to information collected by the INSPECT program.
(4) Identification of emergency situations or other circumstances in which a practitioner may prescribe, dispense, and administer a prescription drug specified in section 17 of this chapter without a written prescription or on a form other than a form specified in section 17(a)(4) of this chapter.
(5) Requirements for a practitioner providing treatment for a patient at an opioid treatment program operating under IC 12-23-18 to check the INSPECT program:
(A) before initially prescribing ephedrine, pseudoephedrine, or a controlled substance to a patient; and
(B) periodically during the course of treatment that uses ephedrine, pseudoephedrine, or a controlled substance.
(b) The board may:
(1) set standards for education courses for individuals authorized to use the INSPECT program;
(2) identify treatment programs for individuals addicted to controlled substances monitored by the INSPECT program; and
(3) work with impaired practitioner associations to provide intervention and treatment.
(c) The executive director of the Indiana professional licensing agency may hire a person to serve as the director of the INSPECT program, with the approval of the chairperson of the board.
(d) The board shall do the following:
(1) Establish a procedure for a practitioner to request a waiver from the requirements of section 19(k) of this chapter if the practitioner does not have access to the Internet at the practitioner’s place of business.
(2) Review a practitioner’s written request for a waiver from the requirements of section 19(k) of this chapter and determine whether the practitioner should be granted a waiver.
(3) Upon determination by the board under subdivision (2) that a practitioner should be granted a waiver under this subsection, issue the practitioner a waiver.
As added by P.L.51-2019, SEC.8.